Back to funds

Knott David M Jr

hedge fundUpdated 10 days ago

Managed by Knott David M Jr • Latest filing Q3 2026

Portfolio value
$182.8M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$215.9M
Q1 2026$168M
Q2 2026$189.2M
Q3 2026$182.8M

Top holdings

82 positions as of Q3 2026

View filing
G

Alphabet Inc-Cl C

Value
$31.1M
Shares
91.2K
% Port
17.00%
A

Apollo Global Management, Inc.

Value
$26.1M
Shares
225.0K
% Port
14.28%
J

Iovance Biotherapeutics, Inc.

Value
$17.3M
Shares
1.17M
% Port
9.44%
X

Xeris Biopharma Holdings, Inc.

Value
$9.6M
Shares
1.00M
% Port
5.24%
S

Syndax Pharmaceutical, Inc.

Value
$8.1M
Shares
428.3K
% Port
4.40%
T

Travere Therapeutics, Inc.

Value
$7.7M
Shares
130.0K
% Port
4.19%
B

Bridgebio Pharma, Inc.

Value
$6.6M
Shares
100.0K
% Port
3.60%
J

JPMorgan Chase & Co.

Value
$5.8M
Shares
17.4K
% Port
3.15%
L

LPL Financial Holdings Inc.

Value
$5M
Shares
16.5K
% Port
2.76%
N

Janus Henderson AAA CLO ETF

Value
$4.7M
Shares
93.5K
% Port
2.58%
A

Alkermes PLC

Value
$4.6M
Shares
114.5K
% Port
2.54%
P

Protagonist Therapeutics, Inc

Value
$4.6M
Shares
32.7K
% Port
2.52%
H

Cybin Inc

Value
$4.5M
Shares
370.0K
% Port
2.49%
C

Cogent Biosciences Inc.

Value
$4.4M
Shares
136.1K
% Port
2.38%
V

Viridian Therapeutics, Inc.

Value
$3.9M
Shares
191.0K
% Port
2.15%
T

TG Therapeutics, Inc.

Value
$3.3M
Shares
59.8K
% Port
1.83%
R

Arcus Biosciences, Inc.

Value
$2.6M
Shares
100.2K
% Port
1.42%
M

Madrigal Pharmaaceuticals, Inc.

Value
$1.8M
Shares
3.6K
% Port
0.99%
R

Relmada Therapeutics, Inc.

Value
$1.8M
Shares
480.0K
% Port
0.99%
S

SPDR S&P Biotech ETF

Value
$1.7M
Shares
11.0K
% Port
0.95%

Explore